The neuropathological changes responsible for cognitive impairment and dementia remain incompletely understood. Longitudinal studies with a brain donation end point allow the opportunity to examine relationships between cognitive status and neuropathology. We report on the first 97 participants coming to autopsy with sufficient clinical information from The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age. This study began in 1983 and recruited 6,542 healthy individuals between 1983 and 1994, 312 of whom consented to brain donation. Alzheimer-type pathology was common throughout the cohort and generally correlated well with cognitive status. However, there was some overlap between cognitive status and measures of Alzheimer pathology with 26% of cognitively intact participants reaching either CERAD B or C, 11% reaching Thal phase 4 or 5, and 29% reaching Braak stage III– VI. Cerebral amyloid angiopathy(CAA), α-synuclein, and TDP-43 pathology was less common, but when present correlated well with cognitive status. Possession of APOEɛ4 allele(s) was associated with more severe Alzheimer-type and CAA pathology and earlier death, whereas possession of APOEɛ2 allele(s) had no effect on pathology but was more common in cognitively intact individuals. The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age cohort is pathologically representative when compared with similar studies. Cognitive impairment in life correlates strongly with all pathologies examined and the APOE status of an individual can affect pathology severity and longevity.
Neuropathology Group of the Medical Research Council CognitiveFunction and Aging Study (2001) Pathological correlates oflate-onset dementia in a multicentre, community-based population inEngland and Wales. Neuropathology Group of the Medical ResearchCouncil Cognitive Function and Ageing Study (MRC CFAS)., Lancet 357, 169–175.
2.
MatthewsFE, BrayneC, LoweJ, McKeithI, WhartonSB, InceP (2009) Epidemiological pathology of dementia: Attributable-risks at deathin the Medical Research Council Cognitive Function and Ageing Study. PLoS Med6, e1000180.
3.
SnowdenDA, Nun Study (2003) Healthy aging and dementia: Findingsfrom the Nun Study.. Ann Intern Med139, 450–454.
4.
BennettDA, SchneiderJA, ArvanitakisZ, WilsonRS (2012) Overviewand findings from the religious orders study.. Curr AlzheimerRes9, 628–645.
5.
National Institute on Ageing (2013) Baltimore Longitudinal Study of Ageing. https://www.blsa.nih.govAccessed January 192018.
6.
Cambridge City over 75 Cohort Study (2005) Cambridge City over 75 Cohort Study, http://www.cc75c.group.cam.ac.ukhttp://www.cc75c.group.cam.ac.uk].Accessed January 19, 2018.
7.
GelberRP, LaunerLJ, WhiteLR (2012) The Honolulu-Asia Aging Study: Epidemiologic and neuropathologic research on cognitive impairment.. Curr Alzheimer Res9, 664–672.
KukullWA, HigdonR, BowenJD, McCormickWC, TeriL, SchellenbergGD, van BelleG, JolleyL, LarsonEB (2002) Dementia and Alzheimerdisease incidence: A prospective cohort study.Arch Neurol59, 1737–1746.
11.
RabbittPMA, McInnesL, DiggleP, HollandF, BentN, AbsonV, PendletonN, HoranM (2004) The University of ManchesterLongitudinal Study of Cognition in Normal Healthy Old Age, 1983 through 2003.Aging Neuropsychol Cogn11, 245–279.
PlassmanBL, WelshKA, HelmsM, BrandtJ, PageWF, BreitnerJC (1995) Intelligence and education as predictors of cognitive statein late life: A 50 year follow-up.Neurology45, 1446–1450.
14.
EvansO, SingletonN, MeltzerD, StewartR, PrinceM (2003) Themental health of older people: Report based on the analysis of theONS survey of psychiatric morbidity among adults in Great BritainOffice of National Statistics (IBSN 0116216603).
15.
ObiK, AkiyamaH, KondoH, ShimomuraY, HasegawaM, IwatsuboT, MizunoY, MochizukiH (2008) Relationship of phosphorylated alpha-synuclein and tau accumulation to Abetadeposition in the cerebral cortex of dementia with Lewy bodies.. Exp Neurol210, 409–420.
16.
MirraSS, HeymanA, McKeelD, SumiSM, CrainBJ, BrownleeLM, VogelFS, HughesJP, van BelleG, BergL (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II.Standardization of the neuropathologic assessment of Alzheimer’sdisease.Neurology41, 479–486.
17.
ThalDR, RübU, OrantesM, BraakH (2002) Phases of Abeta-deposition in the human brain and its relevance for thedevelopment of AD.Neurology58, 1791–1800.
WenhamPR, PriceWH, BlandellG (1991) Apolipoprotein E genotypingby one-stage PCR.Lancet337, 1158–1159.
21.
ChanKS, GrossAL, PezzinLE, BrandtJ, KasperJD (2015) Harmonizingmeasures of cognitive performance across international surveys ofaging using item response theory.J Aging Health27, 1392–1414.
22.
LangaKM, LarsonEB, CrimminsEM, FaulJD, LevineDA, KabetoMU, WeirDR (2017) A comparison of the prevalence of dementia in theUnited States in 2000 and 2012.JAMA Intern Med177, 51–58.
23.
PlassmanBL, LangaKM, FisherGG, HeeringaSG, WierDR, OfstedalMB, BurkeJR, HurdMD, PotterGG, RodgersWL, SteffendDC, WillisRJ, WallaceRB (2007) Prevalence of dementia in the United States: TheAging, Demographics, and Memory Study.Neuroepidemiology29, 125–132.
24.
MillerFD, HicksSP, D’AmatoCJ, LandisJR (1984) A descriptivestudy of neuritic plaques and neurofibrillary tangles in an autopsypopulation.Am J Epidemiol120, 331–341.
25.
NeltnerJH, AbnerEL, JichaGA, SchmittFA, PatelE, PoonLW, MarlaG, GreenRC, DaveyA, JohnsonMA, JazwinskiSM, KimS, DavisD, WoodardJL, KryscioRJ, Van EldikLJ, NelsonPT (2016) Brain pathologies in extreme old age.Neurobiol Aging37, 1–11.
26.
TroncosoJC, MartinLJ, Dal FornaoG, KawasCH (1996) Neuropathologyin controls and demented subjects from the Baltimore LongitudinalStudy of Ageing.Neurobiol Aging17, 365–371.
27.
WolfDS, GearingM, SnowdonDA, MoriH, MarkesberyWR, MirraSS (1999) Progression of regional neuropathology in Alzheimer diseaseand normal elderly: Findings from the Nun study.Alzheimer DisAssoc Disord13, 226–231.
28.
XuerebJH, BrayneC, DufouilC, GertzH, WischikC, HarringtonC, Mukaetova-LadinskaE, McGeeMA, O’SullivanA, O’ConnorD, PaykelES, HuppertFA (2000) Neuropathological findings in the very old.Results from the first 101 brains of a population-based longitudinalstudy of dementing disorders.Ann N Y Acad Sci903, 490–496.
29.
SonnenJA, LarsonEB, CranePK, HaneuseS, LiG, SchellenbergGD, CraftS, LeverenzJB, MontineTJ (2007) Pathological correlates ofdementia in a longitudinal, population-based sample of aging.Ann Neurol62, 406–413.
30.
BancherC, JellingerK, LassmannH, FischerP, LeblhuberF (1996) Correlations between mental state and quantitative neuropathology inthe Longitudinal Study on Dementia.Eur Arch PsychiatryClin Neurosci246, 137–146Vienna.
31.
CummingsBJ, PikeCJ, ShankleR, CotmanCW (1996) Beta-amyloiddeposition and other measures of neuropathology predict cognitivestatus in Alzheimer’s disease. Neurobiol Aging17, 921–933.
32.
GuillozetAL, WeintraubS, MashDC, MesulamMM (2003) Neurofibrillary tangles, amyloid, and memory in aging and mildcognitive impairment. Arch Neurol60, 729–736.
33.
KoepsellTD, KurlandBF, HarelO, JohnsonEA, ZhouXH, KukullWA (2008) Education, cognitive function, and severity of neuropathologyin Alzheimer disease. Neurology70, 1732–1739.
NelsonPT, AbnerEL, SchmittFA, KryscioRJ, JichaGA, SmithCD, DavisDG, PoduskaJW, PatelE, MendiondoMS, MarkesberyWR (2010) Modeling the association between 43 different clinical andpathological variables and the severity of cognitive impairment in alarge autopsy cohort of elderly persons. Brain Pathol20, 66–79.
37.
SabbaghMN, CooperK, DeLangeJ, StoehrJD, ThindK, LahtiT, ReisbergB, SueL, VeddersL, FlemingSR, BeachTG (2010) Functional, global and cognitive decline correlates to accumulationof Alzheimer’s pathology in MCI and AD. Curr Alzheimer Res7, 280–286.
38.
SilverMH, NewellK, BradyC, Hedley-WhiteET, PerlsTT (2002) Distinguishing between neurodegenerative disease and disease-freeaging: Correlating neuropsychological evaluations andneuropathological studies in centenarians. Psychosom Med64, 493–501.
RileyKP, SnowdonDA, MarkesberyWR (2002) Alzheimer’sneurofibrillary pathology and the spectrum of cognitive function:Findings from the Nun Study. Ann Neurol51, 567–577.
45.
EsiriMM, WilcockGK, MorrisJH (1997) Neuropathological assessmentof the lesions of significance in vascular dementia. J NeurolNeurosurg Psychiatry63, 749–753.
46.
TanskanenM, MäkeläM, MyllykangasL, NotkolaIL, PolvikoskiT, SulkavaR, KalimoH, PaetauA (2012) Prevalence and severity ofcerebral amyloid angiopathy: A population-based study on veryelderly Finns (Vantaa 85+). Neuropathol Appl Neurobiol38, 329–336.
47.
PfeiferLA, WhiteLR, RossGW, PetrovitchH, LaunerLJ (2002) Cerebral amyloid angiopathy and cognitive function: The HAAS autopsystudy. Neurology58, 1629–1634.
48.
MikolaenkoI, PletnikovaO, KawasCH, O’BrienR, ResnickSM, CrainB, TroncosoJC (2005) Alpha-synuclein lesions in normal aging,Parkinson’s disease and Alzheimer’s disease: Evidence from theBaltimore Longitudinal Study of Aging (BLSA). J Neuropathol ExpNeurol64, 156–162.
49.
ByfordM, BrayneC, McKeithI, ChatfieldM, InceP, MatthewsF, MRCCFAS Neuropathology group (2009) Lewy bodies and neuronal loss insubcortical areas and disability in non-demented older people: Apopulation based neuropathological cohort study. BMC Geriatr9, 22.
KeageHA, IncePG, MatthewsFE, WhartonSB, McKeithIG, BrayneC, MRC CFAS and CC75C (2012) Impact of less common and “disregarded”neurodegenerative pathologies on dementia burden in apopulation-based cohort. J Alzheimers Dis28, 485–493.
52.
WilsonRS, YuL, TrojanowskiJQ, ChenE, BoylePA, BennettDA, SchneiderJA (2013) TDP-43 pathology, cognitive decline, anddementia in old age. Neurol70, 1418–1424.
53.
KeageHA, HunterS, MatthewsFE, IncePG, HodgesJ, HokkanenS, HighleyJR, DeningT, BrayneC (2014) TDP-43 pathology in thepopulation: Prevalence and associations with dementia and age. J Alzheimers Dis42, 641–650.
54.
NagyZ, EsiriMM, JobstKA, JohnsonC, LitchfieldS, SimE, SmithAD (1995) Influence of the apolipoprotein E genotype on amyloiddeposition and neurofibrillary tangle formation in Alzheimer’sdisease. Neuroscience69, 757–761.
55.
MorrisCM, BenjaminR, LeakeA, McArthurFK, CandyJM, IncePG, TorvikA, BjertnessE, EdwardsonJA (1995) Effect of apolipoprotein E genotype on Alzheimer’s disease neuropathology in a cohort ofelderly Norwegians. Neurosci Lett201, 45–47.
56.
BerlauDJ, CorradaMM, HeadE, KawasCH (2009) epsilon 2 is associated with intact cognition but increased Alzheimerpathology in the oldest old. Neurology72, 829–834.
57.
PolvikoskiT, SulkavaR, HaltiaM, KainulainenK, VuorioA, VerkkoniemiA, NiinistöL, HalonenP, KontulaK (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloidprotein. N Engl J Med333, 1242–1247.
58.
NicollJA, SavvaGM, StewartJ, MatthewsFE, BrayneC, InceP, MRCCFAS (2011) Association betweengenotype, neuropathologyand dementia in the older population of England and Wales. Neuropathol Appl Neurobiol37, 285–294.
WirthM, VilleneuveS, La JoieR, MarksSM, JaqustWJ (2014) Gene-environment interactions: Lifetime cognitive activity,genotype and β-amyloid burden. J Neurosci34, 8612–8617.
61.
SavvaGM, WhartonSB, IncePG, ForsterG, MatthewsFE, Brayne C;Medical Research Council Cognitive Function and Ageing Study (2009) Age, neuropathology and dementia. N Eng J Med360, 2302–2309.
62.
MatthewsFE, ArthurA, BarnesLE, BondJ, JaggerC, RobinsonL, BrayneC, Medical Research Council Cognitive Function and Ageing Collaboration (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 yearsand older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet382, 1405–1412.
63.
SatizabalCL, BeiserAS, ChourakiV, ChêneG, DufouilC, SeshadriS (2016) Incidence of dementia over three decades in theFramingham Heart Study. N Engl J Med374, 523–532.
64.
SnowdenD, GreinerL, MortimerJ, RileyK, GreinerP, MarkesberyW (1997) Brain infarction and the clinical expression of Alzheimer’s disease: The Nun Study. JAMA277, 813–817.
